The time has come. This is your opportunity to discuss your concerns and to share your thoughts on the need for treatment with the United States Food and Drug Administration (FDA). There have been many products brought to market over the last 15 years for male sexual dysfunction, but we still have nothing for women.
The most common female sexual dysfunction is female sexual interest/arousal disorder, often referred to as “low desire” or “low libido.” The FDA wants to hear from women who have this condition. How does it affect your life? What is the most distressing aspect of it? Has anything helped?
On October 27, 2014, the FDA is holding a Patient-Focused Drug Development public meeting on Female Sexual Dysfunction in Silver Springs, Maryland. You can apply to appear in person or submit your comments online. Webcast participants will also have an opportunity to provide input through webcast comments. A panel of patients and patient advocates will present comments to start the dialogue, followed by a facilitated discussion with all patients and patient representatives in the audience. I will be there in person in the audience to hear your comments, and I will also be participating on the scientific panel the following day.
All parts of the event are free but you must register online and by October 20, 2014. For event details and to learn more visit Eventbrite: Patient-Focused Drug Development Public Meeting and Scientific Workshop on Female Sexual Dysfunction event page.
For more information, refer to the FDA meeting website.
Some medical societies are calling into question the annual pelvic exam, at least for those women who have no symptoms and are not pregnant. As you might expect, this topic is being hotly debated.
Those in favor of annual screening pelvic exams argue that sometimes there are abnormalities found in women who have no symptoms. Those opposed to the yearly exam counter that the pelvic exam is not helpful in detecting ovarian cancer or bacterial vaginosis, and was not associated with improved health outcomes or reduction of ovarian cancer mortality rates. They further point out that women can now screen themselves for the common sexually transmitted infections like chlamydia and gonorrhea in the privacy of their own homes.
Harms of testing included false positives, unnecessary surgical procedures, fear, anxiety, embarrassment, pain, and discomfort – particularly for women with a history of sexual violence and/or post-traumatic stress disorder.
Pelvic exams should be tailored to what is in the best interest of each individual woman. Most women do not need a pelvic exam every year but should be sure to see a healthcare provider if they have a new problem or concern. It is important to remember that screening for cervical cancer (with a pap smear, cervical cytology or high risk human papilloma virus test) is still recommended. That is a separate and important issue. The timing interval for cervical cancer screening depends on your age and the findings on your last pap smear.
We strive to bring you the most recent and interesting information about various aspect of menopause and midlife health. We accept no advertising for our website. We want you to have accurate, unbiased, evidence-based information.
This site complies
with the HONcode
information: verify here.